Dr. Jesus G Berdeja, MD
Claim this profileTennessee Oncology
About Jesus G Berdeja, MD
Education:
- Obtained MD from the University of Texas Southwestern Medical School, graduating in 2001.
- Completed Residency in Internal Medicine at Vanderbilt University Medical Center in 2004.
- Finished Fellowship in Hematology/Oncology at Vanderbilt University Medical Center in 2007.
Experience:
- Director of Myeloma Research and Senior Vice President of Clinical Research at Tennessee Oncology.
- Professor of Medicine at Vanderbilt University Medical Center.
Area of expertise
Multiple Myeloma
Jesus G Berdeja, MD has run 16 trials for Multiple Myeloma. Some of their research focus areas include:
Recurrence
Jesus G Berdeja, MD has run 6 trials for Recurrence.
Affiliated Hospitals
Tennessee Oncology
Sarah Cannon Cancer Center
Clinical Trials Jesus G Berdeja, MD is currently running
MMSET Inhibitor
for Multiple Myeloma
This trial tests a new pill that blocks an enzyme to help treat adults with a hard-to-treat type of blood cancer. The goal is to see if it is safe and effective.
Recruiting
1 award
Phase 1
13 criteria
GM T Cell Therapy Long-Term Follow-Up
for Cancer
This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least one infusion of GM T cells will be asked to enroll in this LTFU protocol upon either premature discontinuation from, or completion of the prior parent treatment protocol.
Recruiting
1 award
Phase 2 & 3
More about Jesus G Berdeja, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 19 trials as a Principal Investigator · 4 Active Clinical Trials
Treatments Jesus G Berdeja, MD has experience with
- Dexamethasone
- Daratumumab
- Pomalidomide
- Bortezomib
- Carfilzomib
- Iberdomide
Breakdown of trials Jesus G Berdeja, MD has run
Multiple Myeloma
Recurrence
Plasma Cell Neoplasm
Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jesus G Berdeja, MD specialize in?
Jesus G Berdeja, MD focuses on Multiple Myeloma and Recurrence. In particular, much of their work with Multiple Myeloma has involved t(4;14) positive patients, or patients who are GOF mutation in MMSET positive.
Is Jesus G Berdeja, MD currently recruiting for clinical trials?
Yes, Jesus G Berdeja, MD is currently recruiting for 4 clinical trials in Nashville Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Jesus G Berdeja, MD has studied deeply?
Yes, Jesus G Berdeja, MD has studied treatments such as Dexamethasone, Daratumumab, Pomalidomide.
What is the best way to schedule an appointment with Jesus G Berdeja, MD?
Apply for one of the trials that Jesus G Berdeja, MD is conducting.
What is the office address of Jesus G Berdeja, MD?
The office of Jesus G Berdeja, MD is located at: Tennessee Oncology, Nashville, Tennessee 37203-1625 United States. This is the address for their practice at the Tennessee Oncology.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.